InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: Lykiri post# 187626

Wednesday, 08/29/2018 5:40:45 AM

Wednesday, August 29, 2018 5:40:45 AM

Post# of 701846
If I'd read Laser's initial post on this subject properly, then I would have realised that the EC ratified the EMA decision of approval for Yescarta and Kymriah on Monday.

So NICE waited 1 day from approval to announce that it is not recommending Yescarta at the price level.
Presumably, the NICE verdict on Kymriah will follow in the next week or so, and is likely to be a similar story.

Kite is looking like a very expensive buy for Gilead at $11.9 billion...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News